Clinical diagnostics

Tissue Diagnostic Market – Overview, Analytical Trends And Forecasts, 2015 To 2022

Tissue diagnostics are significant products for monitoring, detecting and treating cancer. The tissue diagnostic market is inclusive of reagents, devices and kits to detect the illness and determineits stage and treatment course. Rising worldwide cancer occurrence and quickly augmenting population of the aged are estimated to be the two most significant drivers of the market. Apart from these, the utilization of tissue diagnostic products in the sector of personalized medicine for cancer management is also predicted to propel the sales of the tissue diagnostic market.

For Market Research Report on “Tissue Diagnostic Market” Visit –

The market, in particular,deals with cancers affecting the prostate, breasts and gastric. The other significant drivers of the tissue diagnostic market include rising demand for safe and reasonably-priced treatment and amplified expenses in medical sector. Also, the coming to fore of advanced technologies and growing demand for proper diagnostic technologies are anticipated to stimulate further market growth. The worldwide tissue diagnostic market is fragmented on account of five categories. These include applications, consumers, technologies, products and geographical regions.

Applications Outlook

The various applications of the tissue diagnostic market are prostate cancers, breast cancers, gastric cancers, lymphoma cancers, and non-small cell lung cancers. Boosting demand for tissue diagnostic products across these applications is also likely to raise further demand for the market. Breast cancer diagnostics of the tissue diagnostic market are anticipated to undergo profitable growththrough the forecast period. This is on account of the rising occurrence of breast cancer. Gastric and prostate cancer diagnostics are also predicted to experience considerable growth over the forecast phase. Modifying dietary habits and growing geriatric population are responsible for the same.

Consumers Insights

The consumer sectors of the tissue diagnostic market include research laboratories, hospitals, contract research establishments and pharmaceutical establishments. Intensified demand for tissue diagnostics across these sectors is also projected to drive the sales of the tissue diagnostic market during the forecast phase. Hospitals are predicted to lead the market in the years to come. This is owing totheir huge effectivity and big procedural volume. Research laboratories are estimated to experience domineering growth in the future. Rising research and development initiatives account for this growth.

Technologies Outlook

The different technologies of the tissue diagnostic market are special staining; immunohistochemistry; digital pathology and workflow; and in-situ hybridization. The sector of immunohistochemistry is projected to capture the biggest share through the forecast period.

Products Overview

The product sectors of the market include accessories and instruments. Accessories leaded the tissue diagnostic market in 2014. This was due to their wide usage in tissue diagnostic procedures.

Regional Insights

North America was the dominating market in 2014. This was in view of favorable reimbursement amenities, increased cancer cases and rising demand for personalized medicines. Europe is estimated to be the second biggest money making tissue diagnostic market. This is owing to augmented awarenessamong patients.The developing nations of Asia Pacific, like China and India are predicted to undergo profitable  expansion in the years to come. This is in view of rising disposable incomes, growing older population, augmented funding for cancer research and huge number of patients.

Tissue Diagnostic Market

Information Source: Grand View Research

Clinical diagnostics

HIV Diagnostics Market – Outlook, Trends And Forecasts, 2015 To 2022

HIV, also known as human immune deficiency virus, spreads through sexual contact with an HIV-infected person. It is the virus that causes AIDS, a condition wherein the body losses its immunity towards infectious diseases and succumbs to them. The HIV diagnostics market deals with all such medical instruments and tests that are utilized to detect whether a person has contracted HIV/AIDS. HIV is found in blood and other body fluids. The worldwide market is estimated to expand to about USD 4.5 billion by the end of 2022.

For Market Research Report on “HIV Diagnostics Market” Visit –


The vital component which is responsible for the expansion of the HIV diagnostics market includes rising requirement for the development of more sensitive point of care tests for HIV detection. These tests can be simply adopted at the site of patient care in resource restricted settings. Technological upgradation of tests which is estimated to bring forth various point of care and novel rapid tests during the forecast phase is another prime factor, positively impacting the HIV diagnostics market.

Moreover, governmental programs and crusades against HIV and worldwide medical attempts towards reducing illnesses are likely to serve as future prospects for the market. Huge unmet needs in the Eastern and Middle Eastern regions of the world also act as future growth opportunities for the HIV diagnostics market. The worldwide market was anticipated at around USD 2, 173 million in 2014. It is likely to expand at about 9.5 percent CAGR through the forecast phase.

Rising HIV population, developments in medical technologies and growing awareness regarding HIV/AIDS are the other critical factors that push further development of the HIV diagnostics market. Shortage of medical labs with advanced facilities and scarcity of skilled medical experts capable of performing routine tests are the two main factors which prevent the market from developing further. Augmented need for easily available, fast HIV and effective diagnostics tests is also expected to propel the sales of the HIV diagnostics market.

The anticipated boost in product offerings to the worldwide market is also poised to support the sales of the market. Laboratory restrictions come in the way of the HIV diagnostics market. Intensifying promiscuous behavior involving multiple partners and growing ‘high risk category’ population also amplify the utilization of HIV diagnostics. This factor also drives further demand for the market.

Significant Findings

HIV diagnostic tests involving the detection of antibodies to HIV occupied the biggest share in 2014. This big share can be credited to the high infiltration rates of HIV tests, such as Elisa, Rapid, Western Blot in theHIV diagnostics market. These tests are very accurate and sensitive and are utilized for the testing and confirmation of HIV. CD4 and Viral Load Testing also captured significant shares in 2014.

Rising HIV diagnostic products are estimated to further the sales of the HIV diagnostics market.North America held the biggest share in 2014. It leaded the worldwide market. This was in view of supportive repayment policies for HIV and other communicable diseases. The Asian Pacific HIV diagnostics market is projected to augment more rapidlythan the North American region through the forecast phase.

HIV Diagnostics Market

Information Source: Grand View Research